As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  5/2/07  Osiris Therapeutics, Inc.         ARS        12/31/06    1:2K                                     SEC #7                   
 3/26/07  Osiris Therapeutics, Inc.         10-K       12/31/06    5:1.7M                                   Toppan Merrill/FA        
 2/14/07  Carmitchel Harry E                5          Officer²    1:4K   Osiris Therapeutics, Inc.         Section16 Direct/FA      
 2/14/07  Mills C Randal                    5          Dir.,Off.²  1:5K   Osiris Therapeutics, Inc.         Section16 Direct/FA      

____________
¹	Filing/Form Types:  -D
	5	Annual Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 5 { The Filer is an Insider² of the Issuer }.
	10-K	Annual Report — Form 10-K.
	ARS	Annual Report to Security Holders.
²	Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.